| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Yaru Lu, Hao Ran, Wenhao Yang, Qian Ma, Li Qiu, Changyi Ou, Pei Chen, Zhongqiang Lin, Weibin Li. AChR myasthenia gravis switching to MuSK or double antibody positive myasthenia gravis in two children and literature review. Neuromuscular disorders : NMD. vol 30. issue 7. 2021-08-11. PMID:32387283. |
achr myasthenia gravis switching to musk or double antibody positive myasthenia gravis in two children and literature review. |
2021-08-11 |
2023-08-13 |
Not clear |
| Min Ju Kim, Seung Woo Kim, MinGi Kim, Young Chul Choi, Seung Min Kim, Ha Young Shi. Evaluating an In-House Cell-Based Assay for Detecting Antibodies Against Muscle-Specific Tyrosine Kinase in Myasthenia Gravis. Journal of clinical neurology (Seoul, Korea). vol 17. issue 3. 2021-07-07. PMID:34184448. |
detecting antibodies against muscle-specific tyrosine kinase (musk abs) is essential for diagnosing myasthenia gravis (mg). |
2021-07-07 |
2023-08-13 |
Not clear |
| Louwai Muhammed, Aravindhan Baheerathan, Michelangelo Cao, Maria Isabel Leite, Stuart Viega. MuSK Antibody-Associated Myasthenia Gravis With SARS-CoV-2 Infection: A Case Report. Annals of internal medicine. vol 174. issue 6. 2021-06-28. PMID:33428437. |
musk antibody-associated myasthenia gravis with sars-cov-2 infection: a case report. |
2021-06-28 |
2023-08-13 |
Not clear |
| Inga Koneczny, Vuslat Yilmaz, Konstantinos Lazaridis, John Tzartos, Tobias L Lenz, Socrates Tzartos, Erdem Tüzün, Frank Leypold. Common Denominators in the Immunobiology of IgG4 Autoimmune Diseases: What Do Glomerulonephritis, Pemphigus Vulgaris, Myasthenia Gravis, Thrombotic Thrombocytopenic Purpura and Autoimmune Encephalitis Have in Common? Frontiers in immunology. vol 11. 2021-06-21. PMID:33584677. |
it has only recently been appreciated, that members of this group share relevant immunobiological and therapeutic aspects even though different antigens, tissues and organs are affected: glomerulonephritis (kidney), pemphigus vulgaris (skin), thrombotic thrombocytopenic purpura (hematologic system) muscle-specific kinase (musk) in myasthenia gravis (peripheral nervous system) and autoimmune encephalitis (central nervous system) to give some examples. |
2021-06-21 |
2023-08-13 |
Not clear |
| Ruoyi Jiang, Miriam L Fichtner, Kenneth B Hoehn, Minh C Pham, Panos Stathopoulos, Richard J Nowak, Steven H Kleinstein, Kevin C O'Conno. Single-cell repertoire tracing identifies rituximab-resistant B cells during myasthenia gravis relapses. JCI insight. vol 5. issue 14. 2021-05-21. PMID:32573488. |
to further define the mechanisms that cause postrituximab relapse, we studied patients with autoantibody-mediated muscle-specific kinase (musk) myasthenia gravis (mg) who relapsed after treatment. |
2021-05-21 |
2023-08-13 |
Not clear |
| Rika Yamashita, Mikito Shimizu, Kousuke Baba, Goichi Beck, Makoto Kinoshita, Tatsusada Okuno, Osamu Higuchi, Hideki Mochizuk. Anti-MuSK Positive Myasthenia Gravis with Anti-Lrp4 and Anti-titin Antibodies. Internal medicine (Tokyo, Japan). vol 60. issue 1. 2021-04-14. PMID:32830177. |
in addition to muscle nicotinic acetylcholine receptor (achr) and muscle-specific kinase (musk), low-density lipoprotein receptor (lrp4) has recently been discovered to be a novel target antigen among patients with seronegative myasthenia gravis (mg). |
2021-04-14 |
2023-08-13 |
Not clear |
| Mariapaola Marino, Umberto Basile, Gregorio Spagni, Cecilia Napodano, Raffaele Iorio, Francesca Gulli, Laura Todi, Carlo Provenzano, Emanuela Bartoccioni, Amelia Evol. Long-Lasting Rituximab-Induced Reduction of Specific-But Not Total-IgG4 in MuSK-Positive Myasthenia Gravis. Frontiers in immunology. vol 11. 2021-03-25. PMID:32431692. |
the use of rituximab (rtx), an anti-cd20 monoclonal antibody (ab), in refractory myasthenia gravis (mg) is associated with a better response in patients with abs to the muscle-specific tyrosine kinase (musk) than in other mg subgroups. |
2021-03-25 |
2023-08-13 |
Not clear |
| Lucia S Borges, David P Richma. Muscle-Specific Kinase Myasthenia Gravis. Frontiers in immunology. vol 11. 2021-03-25. PMID:32457737. |
thirty to fifty percent of patients with acetylcholine receptor (achr) antibody (ab)-negative myasthenia gravis (mg) have abs to muscle specific kinase (musk) and are referred to as having musk-mg. musk is a 100 kd single-pass post-synaptic transmembrane receptor tyrosine kinase crucial to the development and maintenance of the neuromuscular junction. |
2021-03-25 |
2023-08-13 |
Not clear |
| Debby Reuveni, Revital Aricha, Miriam C Souroujon, Sara Fuch. MuSK EAMG: Immunological Characterization and Suppression by Induction of Oral Tolerance. Frontiers in immunology. vol 11. 2021-03-23. PMID:32256489. |
myasthenia gravis (mg) with antibodies to the muscle-specific receptor tyrosine kinase (musk) is a distinct sub-group of mg, affecting 5-8% of all mg patients. |
2021-03-23 |
2023-08-13 |
mouse |
| Miriam L Fichtner, Casey Vieni, Rachel L Redler, Ljuvica Kolich, Ruoyi Jiang, Kazushiro Takata, Panos Stathopoulos, Pablo A Suarez, Richard J Nowak, Steven J Burden, Damian C Ekiert, Kevin C O'Conno. Affinity maturation is required for pathogenic monovalent IgG4 autoantibody development in myasthenia gravis. The Journal of experimental medicine. vol 217. issue 12. 2021-03-11. PMID:32820331. |
pathogenic muscle-specific tyrosine kinase (musk)-specific igg4 autoantibodies in autoimmune myasthenia gravis (mg) are functionally monovalent as a result of fab-arm exchange. |
2021-03-11 |
2023-08-13 |
Not clear |
| Sam Arman, Norman Kock, George Mochloulis, Gorande Kanaba. Bilateral vocal fold paresis: the only presenting sign of anti-MUSK antibody myasthenia gravis. BMJ case reports. vol 14. issue 1. 2021-02-24. PMID:33436356. |
electromyography and serum antibody testing confirmed a diagnosis of anti-muscle-specific tyrosine kinase antibody positive myasthenia gravis (musk-mg); a subset of mg where autoantibodies are directed against musk. |
2021-02-24 |
2023-08-13 |
Not clear |
| Saif Huda, Michelangelo Cao, Anna De Rosa, Mark Woodhall, Pedro M Rodriguez Cruz, Judith Cossins, Michelangelo Maestri, Roberta Ricciardi, Amelia Evoli, David Beeson, Angela Vincen. SHP2 inhibitor protects AChRs from effects of myasthenia gravis MuSK antibody. Neurology(R) neuroimmunology & neuroinflammation. vol 7. issue 1. 2021-02-15. PMID:31831571. |
shp2 inhibitor protects achrs from effects of myasthenia gravis musk antibody. |
2021-02-15 |
2023-08-13 |
Not clear |
| Gregory T Greenwood, Zachary Lync. Successful Transition from Plasma Exchange to Eculizumab in Acetylcholine Receptor Antibody- and Muscle-Specific Kinase (MuSK) Antibody-Negative Myasthenia Gravis: A Case Report. The American journal of case reports. vol 21. 2021-01-15. PMID:32417849. |
successful transition from plasma exchange to eculizumab in acetylcholine receptor antibody- and muscle-specific kinase (musk) antibody-negative myasthenia gravis: a case report. |
2021-01-15 |
2023-08-13 |
Not clear |
| Ruth Herbs. MuSk function during health and disease. Neuroscience letters. vol 716. 2020-12-14. PMID:31811897. |
defects in musk signaling are the cause of muscle weakness as reported in congenital myasthenic syndromes and myasthenia gravis. |
2020-12-14 |
2023-08-13 |
Not clear |
| Evgenii Bogatikov, Ida Lindblad, Tanel Punga, Anna Rostedt Pung. miR-1933-3p is upregulated in skeletal muscles of MuSK+ EAMG mice and affects Impa1 and Mrpl27. Neuroscience research. vol 151. 2020-12-04. PMID:30763589. |
musk antibody seropositive (musk+) myasthenia gravis (mg) typically affects skeletal muscles of the bulbar area, including the omohyoid muscle, causing focal fatigue, weakness and atrophy. |
2020-12-04 |
2023-08-13 |
mouse |
| Yingkai Li, Jeffrey T Guptill, Melissa A Russo, James F Howard, Janice M Massey, Vern C Juel, Lisa D Hobson-Webb, Doug Emmett, Manisha Chopra, Shruti Raja, Weibin Liu, John S Y. Imbalance in T follicular helper cells producing IL-17 promotes pro-inflammatory responses in MuSK antibody positive myasthenia gravis. Journal of neuroimmunology. vol 345. 2020-11-10. PMID:32497931. |
imbalance in t follicular helper cells producing il-17 promotes pro-inflammatory responses in musk antibody positive myasthenia gravis. |
2020-11-10 |
2023-08-13 |
Not clear |
| Zunwei Zhang, Yujia Guan, Jiale Han, Mingming Li, Miao Shi, Hui Den. Regional Features of MuSK Antibody-Positive Myasthenia Gravis in Northeast China. Frontiers in neurology. vol 11. 2020-10-31. PMID:33123066. |
regional features of musk antibody-positive myasthenia gravis in northeast china. |
2020-10-31 |
2023-08-13 |
Not clear |
| Mingqin Zhu, Vanda A Lenno. Double seropositivity for AChR and MuSK autoantibodies in myasthenia gravis. Neuromuscular disorders : NMD. vol 30. issue 7. 2020-10-29. PMID:32527590. |
double seropositivity for achr and musk autoantibodies in myasthenia gravis. |
2020-10-29 |
2023-08-13 |
Not clear |
| T J S Bekooij, H J Gilhuis, L Dawson, E H Nik. Dysautonomia as the Presenting Symptom in Anti-Muscle-Specific Kinase Antibody Myasthenia Gravis. Journal of neuromuscular diseases. vol 7. issue 1. 2020-10-13. PMID:31868676. |
in an minority of myasthenia gravis (mg) patients, the autoantibodies bind to muscle-specific kinase (musk). |
2020-10-13 |
2023-08-13 |
Not clear |
| Seung Woo Kim, Mun Kyung Sunwoo, Seung Min Kim, Ha Young Shin, Il Nam Sunwo. Repetitive Nerve Stimulation in MuSK-Antibody-Positive Myasthenia Gravis. Journal of clinical neurology (Seoul, Korea). vol 13. issue 3. 2020-09-30. PMID:28516744. |
responses to repetitive nerve stimulation (rns) in patients with muscle-specific tyrosine kinase (musk) antibody (ab)-positive myasthenia gravis (mg) vary depending on the muscles tested. |
2020-09-30 |
2023-08-13 |
Not clear |